{"filings":[{"id":2282439,"accession_number":"0001213900-26-090472","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-08-17T11:00:14+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Enovix CEO Raj Talluri resigns; CFO Ryan Benton named interim CEO, T.J. Rodgers executive chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Raj Talluri resigned as CEO and director effective Aug 13, 2026 to pursue another opportunity; not due to disagreement.","Board appointed T.J. Rodgers (largest shareholder, former non-exec chairman) as Executive Chairman, and CFO Ryan Benton as interim CEO.","Company reaffirms Q3 2026 financial guidance provided Aug 12, 2026; defense/drone revenue was 65% of Q2'26 revenue.","Q2'26 demonstrated 1,000-cycle life on AI-class smartphone batteries with 100% silicon anodes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2216998,"accession_number":"0001828318-26-000055","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-08-12T20:12:13+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q2 revenue $9.0M up 21% YoY at high end; smartphone qualification test underway","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $9.0M (+21% YoY, +19% QoQ) at high end; H1 $16.6M (+32%). Q3 guidance $9-10M.","GAAP EPS -$0.20, non-GAAP -$0.13; GAAP gross margin 14.4%, non-GAAP 19.9%, down on mix shift.","Lead smartphone customer confirms >1,000 cycles; final accelerated cycle-life test to complete Q4 2026.","Smart eyewear: shipped ~2,100 AI-1 batteries, initial revenue; Q3 shipments ~19,000 packs (9x QoQ) under 50,000-pack order.","Drone/defense/industrial pipeline $183M (+41% QoQ); COO Michael Vyvoda appointed; cash $552.1M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1535596,"accession_number":"0001828318-26-000050","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-07-09T11:35:21+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints former Apple operations leader Michael Vyvoda as COO effective July 29, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Michael Vyvoda, former Apple Director of Product Operations for AirPods, named COO effective July 29, 2026.","Compensation: $440,000 base salary, 60% target bonus, $4M RSUs (25% vest after 12 months, then quarterly), $100K fully vested RSUs.","Vyvoda will lead global manufacturing, supply chain, and operations engineering across Malaysia, Korea, and India facilities.","Enovix reported Q1 2026 revenue of $7.6M (+49% YoY), pipeline >$130M for Korea products, and first commercial order of ~50,000 units for smart eyewear."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1028556,"accession_number":"0001828318-26-000046","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-06-12T20:37:56+00:00","items":["5.07"],"status":"ready","headline":"Enovix 2026 annual meeting results: all director nominees elected, say-on-pay passed, Deloitte ratified","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 8 director nominees re-elected: each received >73M votes for; broker non-votes ~63.7M each.","Say-on-pay approved: 72.7M for, 15.4M against, 1.3M abstain.","Ratification of Deloitte & Touche as auditor: 148.9M for, 2.8M against, 1.4M abstain.","Quorum established with 153.2M shares voted, representing 70.3% of outstanding stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":68645,"accession_number":"0001828318-26-000027","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-05-13T20:18:39+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 revenue $7.6M (+49% YoY); starts smart eyewear battery production; advances smartphone qualification","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.6M, up 49% YoY, above guidance high end; GAAP net loss $0.18/sh, non-GAAP loss $0.14/sh.","Began commercial production of silicon-anode smart eyewear battery; expects to ship ~50,000 units in 2026.","Smartphone qualification: 72 of 75 battery specs passed; new silicon-specific framework adopted with lead customer.","Launched MX-1 drone cell with 360 Wh/kg; Korea product pipeline exceeds $130M, driven by drone demand.","Cash $582.7M; Q2 guidance revenue $8-9M, non-GAAP EPS loss $(0.13-0.17)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95913,"accession_number":"0001828318-26-000022","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix appoints Steve Bakos as SVP Worldwide Sales; aligns with lead smartphone customer on new qualification framework","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steve Bakos appointed SVP Worldwide Sales, effective May 5, 2026; reports to Chief Business Officer Samira Naraghi.","Bakos previously VP of Corporate Account Sales at Infineon Technologies handling Apple; 35 years semiconductor sales experience.","Aligned with lead smartphone customer on silicon-specific qualification framework that extends testing duration and improves field performance confidence.","Results from updated framework approaching required performance thresholds, addressing a primary structural barrier to qualification.","Growing sales pipelines and increased demand across smartphones, smart eyewear, drone, and defense applications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109342,"accession_number":"0001828318-26-000005","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Enovix Q4 revenue $11.3M, FY revenue $31.8M (+38% YoY); board authorizes $75M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $11.3M (record, up 16% YoY from $9.7M); FY2025 revenue $31.8M (up 38% from $23.1M).","GAAP net loss per share ($0.16) in Q4, ($0.75) for FY; non-GAAP loss per share ($0.14) and ($0.54).","Non-GAAP gross margin improved to 23% in FY2025 from 0.9% in FY2024; cash & marketable securities $621M.","Smartphone qualification progressing; cycle-life high-power testing is key gating item for commercialization.","Board authorized additional $75M share repurchase; Q1 2026 revenue guidance $6.5-7.5M, non-GAAP loss from ops ($29-32M)."],"consensus_eps_estimate":-0.1798,"consensus_eps_actual":-0.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":31821000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109341,"accession_number":"0001628280-26-002494","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Enovix COO retiring Feb 17; preliminary 2025 revenue growth ~38%","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Ajay Marathe to retire effective Feb 17, 2026; no disagreement cited.","Preliminary unaudited 2025 revenue grew ~38% YoY, driven by Korea battery business.","SVP Kihong Park expands role to lead Global Manufacturing Operations for scale-up.","Ed Casey (ex-Komag, Seagate, ams OSRAM) hired as VP Operations for AME equipment.","Company targeting mass production for smartphones, smart eyewear, and defense."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125818,"accession_number":"0001828318-25-000308","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q3 revenue $8M (+85% YoY), beats guidance; raises Q4 revenue view to $9.5-10.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $8.0M (+85% YoY), above prior guidance $7.5-8.5M; Q4 revenue guidance raised to $9.5-10.5M.","GAAP gross margin improved to 18% (from -15% YoY); non-GAAP gross margin 21%.","GAAP diluted net loss $0.27/sh; non-GAAP diluted net loss $0.14/sh, within guidance range.","Cash, equivalents & marketable securities $648M (vs $201M a year ago) after convertible note issuance and warrant dividend.","Lead smartphone customer advancing AI-1 battery; independent validation as highest energy density; Fab2 yield improvements progressing."],"consensus_eps_estimate":-0.1598,"consensus_eps_actual":-0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":20556000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142567,"accession_number":"0001828318-25-000300","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Enovix closes $360M convertible note offering at 4.75% due 2030; conversion price $11.21","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$360M aggregate principal of 4.75% convertible senior notes due Sept 15, 2030; conversion price $11.21 (22.5% premium over last sale).","Net proceeds ~$348.6M; used ~$45.3M to pay for capped call transactions that reduce dilution.","Capped calls with six, twelve, eighteen, and thirty-six month expirations; cap prices range $16.47–$20.13 (avg 100% premium).","Remaining proceeds earmarked for general corporate purposes, including potential battery-ecosystem acquisitions that may be EBITDA accretive.","Initial purchasers' over-allotment option for additional $60M exercised in full."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142566,"accession_number":"0001828318-25-000295","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix completes warrant dividend financing; no financial details disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Enovix updated its investor presentation following the conclusion of its warrant dividend financing.","No specific financial figures, milestones, or guidance changes were provided in the 8-K or exhibit.","The only exhibit content shown is the presentation title 'Investor Overview September 2025'."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142565,"accession_number":"0001828318-25-000293","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix completes warrant dividend program, raises $232.1M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approximately 26.5M warrants exercised, generating $232.1M gross proceeds for Enovix.","Private warrant exercise price adjusted from $11.50 to $10.66 per warrant; 5.5M outstanding.","As of Sept 5, 2025, company repurchased 5,437,556 shares under its buyback program.","CEO says proceeds will accelerate Fab2 production and potential battery ecosystem acquisitions.","Warrants expired and ceased trading on Aug 29, 2025; program concluded."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142564,"accession_number":"0001828318-25-000289","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix warrants expire Aug 29; price condition met, 12.6M exercised for $110M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Alternate price condition satisfied; warrants expire Aug 29, 2025; trading ends at 4pm ET, exercise deadline 5pm ET.","Approximately 12.6 million warrants cash-exercised at $8.75 each, yielding ~$110.1 million gross proceeds to date.","Unexercised warrants after deadline are void; holders lose all rights.","Notice of guaranteed delivery available for late exercise submissions before 5pm ET Aug 29."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142563,"accession_number":"0001828318-25-000286","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix warrants early expiration triggered; final exercise Aug 29; $107.5M proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["VWAP exceeded $10.50 triggering early expiration; alternate expiration date set for Aug 29, 2025.","Warrants must be exercised by 5 p.m. ET on Aug 29; trading on Nasdaq ends at 4 p.m. ET.","Approximately 12.3M warrants exercised so far, generating ~$107.5M in gross proceeds.","Exercise price is $8.75 per warrant; each warrant buys one share of ENVX common stock.","Notice of Guaranteed Delivery available for holders who cannot complete exercise on time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142562,"accession_number":"0001828318-25-000281","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix reappoints veteran semiconductor leader Dan McCranie to Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed J. Daniel 'Dan' McCranie to Board effective Aug 12, 2025; Board expands to 8 directors, 6 independent.","McCranie previously served on Enovix Board (resigned Jan 2023); brings 30+ years semiconductor governance and ops experience.","Compensation: $50k annual cash retainer, initial RSU grant of $275k vesting over 3 years, annual RSU of $195k prorated.","Former Chairman of onsemi, Non-Executive Chairman of Freescale; currently SunPower director and EVP of Sales."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142561,"accession_number":"0001828318-25-000273","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q2 revenue $7.5M (+98% YoY); AI-1 platform launched; non-GAAP EPS loss $0.13 beats guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $7.5M beat guidance of $4.5-6.5M; third consecutive quarter of positive gross margin (non-GAAP 31%).","Non-GAAP net loss per share $0.13 better than guidance ($0.15-$0.21); GAAP net loss $0.22.","AI-1 platform launched with first smartphone battery >900 Wh/L; samples shipped to two top smartphone OEMs.","Cash $203.4M; warrant dividend to raise up to $255M; Board authorized $60M share repurchase program.","Q3 guidance: revenue $7.5-8.5M, non-GAAP operating loss $31-35M, non-GAAP EPS loss $0.14-$0.18."],"consensus_eps_estimate":-0.1711,"consensus_eps_actual":-0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":12566000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142560,"accession_number":"0001828318-25-000271","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix stock price triggers potential early warrant expiration as early as Aug 19","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Common stock closed at $15.06, above $10.50 threshold for five trading days.","Warrants (ENVXW) exercisable at $8.75 per share; earliest expiration date Aug 19, 2025.","Company reserves right to set Alternate Expiration Date if stock stays above $10.50 for 20 of 30 days.","CFO Ryan Benton confirms intention to accelerate expiration if condition is met, with follow-on notice.","Warrants remain tradable and exercisable each day through expiration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142559,"accession_number":"0001828318-25-000264","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-21T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Enovix distributes warrant dividend: 1 warrant per 7 shares, exercise $8.75, early expiration if stock >$10.50","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Record date July 17, 2025; distribution date July 21, 2025; one warrant per seven shares held, rounded down.","Each warrant exercisable at $8.75 per share; expires Oct 1, 2026, but early expiration triggered if VWAP ≥ $10.50 for 20 of 30 trading days.","Stock closed at $15.54 on July 18 – if VWAP stays above $10.50, warrants could expire as early as Aug 19, 2025.","Warrants to trade on Nasdaq under ENVXW starting July 22; up to ~29.2M shares reserved upon exercise.","Holders of 3.00% Convertible Notes due 2028 also receive warrants on same ratio (9.1543 per $1,000 face)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142558,"accession_number":"0001828318-25-000252","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix issues supplemental FAQ on warrant dividend; warns margin-account holders may miss exercisable warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Record date July 17, 2025; distribution date on/about July 21, 2025; one warrant per 7 shares held.","Approx. 29M warrants to be issued; exercise price $8.75; warrants expected to trade under ENVXW.","Early expiration trigger: VWAP >= $10.50 for 20 of 30 trading days; otherwise expire Oct 1, 2026.","Shares held in margin accounts may be loaned out; holders must transfer to cash account by record date to receive actual exercisable warrants.","Non-U.S. shareholders eligible; call option holders not entitled; last day to buy shares for warrant eligibility is July 16, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142557,"accession_number":"0001828318-25-000225","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-07T23:59:59+00:00","items":["8.01","7.01","9.01"],"status":"ready","headline":"Enovix declares warrant dividend: 1 warrant per 7 shares, $8.75 exercise, up to $253.8M proceeds","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Each common stockholder receives 1 warrant for every 7 shares held as of July 17, 2025 record date.","Warrants exercisable at $8.75/share; if all ~29M warrants exercised, gross proceeds up to $253.8M.","Warrants expire Oct 1, 2026 unless early expiration triggered if stock VWAP >= $10.50 for 20 of 30 trading days.","Warrants expected to trade on Nasdaq under ticker ENVXW shortly after distribution date ~July 21, 2025.","Convertible noteholders also receive warrants on as-converted basis (9.1543 per $1,000 principal)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142556,"accession_number":"0001828318-25-000223","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Enovix Q2 rev $7.5M (+98% YoY), beats guidance; GAAP gross profit positive 3rd straight quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $7.5M, up 98% YoY, exceeded guidance of $4.5M-$6.5M.","GAAP gross profit $0.8M; third consecutive quarter of positive GAAP and non-GAAP gross profit.","Non-GAAP operating loss $27.8M beat guid range $31M-$37M; GAAP op loss $43.8M.","Adjusted EBITDA loss $21.4M, ahead of guidance ($23M-$29M) and improved from $26.4M YoY.","Cash $203M after SolarEdge asset acquisition; GAAP net loss per share $0.22, non-GAAP $0.15."],"consensus_eps_estimate":-0.1711,"consensus_eps_actual":-0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":12566000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142555,"accession_number":"0001828318-25-000220","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Enovix authorizes $60M share repurchase program through Dec 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $60M of common stock; effective June 30, 2025, expires Dec 31, 2026.","Repurchases may be made via open-market or private transactions; timing and amount at company discretion.","Program can be modified, suspended, or discontinued; no obligation to buy any specific number of shares.","CFO Ryan Benton cites confidence in long-term fundamentals and 100% silicon-anode battery technology."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160617,"accession_number":"0001828318-25-000209","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enovix shareholders elect all seven directors, approve say-on-pay and auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected with 64-71M votes for each; broker non-votes were 57.3M.","Advisory vote on executive compensation approved: 55.0M for, 16.6M against, 583,653 abstain.","Ratification of Deloitte as auditor for FY2025 approved with 126.2M for, 1.9M against.","Quorum of 67.5% (129.5M shares) present at the June 12 annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160616,"accession_number":"0001828318-25-000141","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 revenue $5.1M, beats guidance midpoint; net loss $0.12/share; guides Q2 revenue $4.5-6.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $5.1M (near high end of guidance); GAAP net loss $23.5M ($0.12 loss per share).","Non-GAAP net loss per share $0.15; Adjusted EBITDA loss $22.2M.","Q2 2025 revenue guidance $4.5-6.5M; non-GAAP operating loss $31-37M.","Acquired SolarEdge assets in South Korea for $10M to expand coating capacity and defense programs.","Appointed Ryan Benton as CFO and Samira Naraghi as CBO."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":5098000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160615,"accession_number":"0001828318-25-000115","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-04-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints Ryan Benton as CFO effective April 14, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ryan Benton was appointed CFO effective April 14, 2025; over 30 years of financial leadership experience.","Compensation includes $425,000 base salary, 60% target bonus, and $4.5M RSU grant vesting over 5 years.","Benton's first public appearance as CFO will be on Q1 2025 earnings call April 30.","CEO states nearing smartphone battery mass production; chairman notes Routejade acquisition benefit."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160614,"accession_number":"0001828318-25-000087","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Enovix acquires SolarEdge battery cell manufacturing facility in South Korea","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires ~330,000 sq ft facility directly adjacent to existing Nonsan City plant; deal expected to close April 2025.","Plans to hire certain SolarEdge Korea personnel in manufacturing, quality, R&D and process engineering.","Projected sales increase in 2025-2026 with higher mix toward defense and industrial applications; expects improved gross margins.","Facility has been operating for over 20 years; acquisition aims to expand capacity and expedite scaled production."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178850,"accession_number":"0001828318-25-000050","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-02-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix reports record Q4 revenue $9.7M; first positive gross margin; smartphone samples shipped","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $9.7M (record), full-year $23.1M, up 202% YoY; first positive GAAP gross margin of $1.1M (11% of sales).","GAAP net loss $37.5M ($0.20 EPS loss); non-GAAP EPS loss $0.11; adjusted EBITDA loss $11.7M improved from -$21.6M Q3.","Cash and equivalents $272.9M at year-end; Q1 2025 guidance: revenue $3.5M-$5.5M, GAAP EPS loss $0.23-$0.29.","Shipped early smartphone battery samples to lead OEM; secured purchase orders from 7 of top 8 smartphone OEMs and an AI/XR leader.","Fab2 in Malaysia completed Site Acceptance Testing for HVM line; first EX-2M samples shipped on schedule."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":23074000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178849,"accession_number":"0001828318-25-000003","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2025-01-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints Kristina Truong as first SVP & Chief Accounting Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kristina Truong named SVP and Chief Accounting Officer, effective Dec 30, 2024.","Truong, 53, joined Enovix in June 2022; previously Corporate Controller at Spruce Biosciences and Outset Medical.","She will oversee all accounting, controllership, financial reporting, and SOX controls.","Appointment adds new CAO role to support growth across five international geographies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195520,"accession_number":"0001828318-24-000271","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-12-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix CFO Farhan Ahmad departs; company initiates search for replacement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Farhan Ahmad left effective immediately, not due to disagreement with operations or policies.","Company is searching for a new CFO with strong investor relations and transparent communication.","Enovix holds over $250M cash, reduced cost structure, and financial runway for Penang factory ramp.","Executive Chairman T.J. Rodgers commits to more transparent investor communications going forward."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195519,"accession_number":"0001193125-24-249316","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Enovix prices $100M public offering of 10.4M shares at $9.22/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $100M from 10,416,667 shares at $9.22 per share; underwriter option for 1,562,500 additional shares.","Offering expected to close on November 1, 2024, with Cantor Fitzgerald as sole bookrunner.","Net proceeds will fund general corporate purposes, working capital, and Fab2 high-volume manufacturing in Penang, Malaysia.","Shelf registration statement on Form S-3 declared effective August 18, 2023; prospectus supplement filed with SEC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195518,"accession_number":"0001828318-24-000229","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q3 revenue $4.3M, GAAP net loss $22.5M; opens Fab2, secures second smartphone OEM partnership","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.3M (above guidance midpoint), up from $3.8M Q2; GAAP net loss $22.5M improved from $115.9M Q2.","Opened Fab2 in Malaysia; commenced shipping EX-1M cells; completed UN38.3 safety certification.","Signed development agreement with second leading smartphone OEM for mass production launch in late 2025.","Q4 2024 guidance: revenue $8-10M, GAAP EPS loss $0.23-0.29, adjusted EBITDA loss $19-25M.","Cash $200.9M at quarter-end; on track to reduce cash consumption with Malaysia ops."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":13357000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211788,"accession_number":"0001828318-24-000155","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q2 revenue $3.8M, beats guidance; Malaysia Agility Line producing first batteries","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss $115.9M vs $46.4M in Q1; includes $38.1M restructuring and $33.7M warrant expense.","Non-GAAP EPS loss $0.14; adjusted EBITDA loss $23.1M; cash & equivalents $249.9M at quarter-end.","Signed agreements with California tech company (mixed reality headset) and Fortune 200 firm (IoT).","Second automotive OEM MOU signed in 2024; Malaysia Agility Line operational, Gen2 Autoline FAT done.","Q3 guidance: revenue $3.5-4.5M, GAAP EPS loss $0.30-0.36, non-GAAP EPS loss $0.17-0.23."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.95,"consensus_revenue_estimate":null,"consensus_revenue_actual":9040000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230533,"accession_number":"0001828318-24-000126","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-06-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enovix stockholders elect all seven directors, approve say-on-pay, ratify Deloitte auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 7 director nominees elected: Rodgers, Atkins, Ebrahimi, Gutmann, Malchow, Reichow, Talluri.","Advisory vote on executive compensation approved with 79% of votes cast in favor (53.6M for, 13.8M against).","Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 112.2M for, 0.7M against.","Broker non-votes of approximately 46M shares on director elections and say-on-pay.","Director Betsy Atkins received 11.1M withheld votes, highest among nominees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230532,"accession_number":"0001828318-24-000062","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-05-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 revenue $5.3M beats guidance; non-GAAP gross profit positive for first time","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $5.3M (up from $21K YoY) exceeded guidance of $3.5-4.5M; non-GAAP gross profit turned positive.","GAAP EPS loss $0.28; non-GAAP EPS loss $0.31; Adjusted EBITDA loss $26.3M.","Fab2 Gen2 Agility Line FAT complete; EX-1M sampling in Q2; development deal with top-5 smartphone OEM.","Targeting >$35M annual fixed cost cut by year-end; cash $262.4M at quarter-end.","Q2 2024 guidance: revenue $3-4M, adjusted EBITDA loss $26-32M, non-GAAP EPS loss $0.22-0.28."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":5272000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248919,"accession_number":"0001828318-24-000012","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2024-02-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q4 revenue $7.4M, record top line; Fab2 on track for April samples","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $7.4M vs $0.2M Q3 and $1.1M YoY; driven by Routejade acquisition and Army shipments.","Fab2 in Malaysia built 250k sq ft; first silicon samples expected April 2024; Gen2 equipment arriving.","Entered development agreement with a leading automaker for EV battery; collaboration with Group14.","Plans to sample EX-1M smartphone battery in Q2 2024, targeting 1,000 cycles with 100% active silicon anode.","Q1 2024 guidance: revenue $3.5-4.5M, adjusted EBITDA loss $24-31M, EPS loss $0.29-$0.35."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":7644000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266464,"accession_number":"0001828318-23-000202","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q3 revenue $0.2M; cash $371.3M; narrows FY2023 cash use guidance to $110M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $0.2M from U.S. Army cells; GAAP cost of revenue $16.8M; GAAP op. expenses $33.8M.","Cash, equivalents, and short-term investments $371.3M; Q3 operating cash use $28.2M; capex $17.3M.","FY2023 operational cash use forecast lowered to $110M (from $120M); capex to $65M (from $70M).","Completed FAT for one Gen2 production zone; expects all four zones FAT by Jan 2024; first samples by Apr 2024.","Acquired Routejade for electrode coating; Fab1 restructuring reduces annualized cash burn ~$22M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":263000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266463,"accession_number":"0001828318-23-000198","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix cuts workforce by 185; shifts Fab1 from manufacturing to R&D; misses Q3 cell production guidance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Workforce reduction of ~185 personnel (including over 125 contractors) with restructuring charge of ~$2.5M.","Accelerated depreciation of $36M for Gen1 equipment in Q4 2023–Q1 2024; annualized savings of $22M from restructuring.","Q3 2023 small cell production cut to 24,000 units vs. guidance of 36,000; expected Q3 revenue only ~$0.2M.","Fab1 becomes 'Center for Innovation' for R&D; high-volume manufacturing to shift to Asia.","Strategy pivots from standard cells to custom cells for large customers like smartphone OEMs and U.S. Army."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283703,"accession_number":"0001828318-23-000196","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-09-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix board member Emmanuel Hernandez to retire; Gutmann becomes Audit Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Emmanuel T. Hernandez retires from Enovix board effective Sept. 30, 2023; not due to any disagreement.","Bernard Gutmann appointed Audit Committee Chairman effective Oct. 1, 2023; receives $22,000 annual retainer.","Joseph Malchow appointed to Audit Committee effective Oct. 1, 2023; receives $10,000 annual retainer.","Hernandez joined board in July 2021 when Enovix went public; cited planned retirement from board roles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283702,"accession_number":"0001828318-23-000193","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-09-20T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Enovix acquires Routejade for ~$16.5M cash + 6.2M shares; accretive, vertical integration","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration of ~6.2M Enovix shares and ~$16.5M cash for 100% of Routejade.","Acquisition verticalizes electrode coating and battery pack manufacturing; expected to reduce future capex by ~$35M.","Routejade is a qualified supplier of coated rolls for Enovix batteries, supporting Fab2 scale-up starting 2024.","Transaction expected to close in Q4 2023 and be immediately accretive; Routejade CEO Kihong Park will continue to run the business.","Establishes Enovix presence in Korea near customers, equipment suppliers, and raw material suppliers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283701,"accession_number":"0001828318-23-000189","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-09-14T23:59:59+00:00","items":["1.01","2.03"],"status":"ready","headline":"Enovix enters deposit agreement to collateralize $70M loan for Malaysia manufacturing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Enovix will deposit cash into a restricted OCBC account equal to OSSB drawdowns under a $70M loan for manufacturing.","No cash deposits expected in quarter ending Oct 1, 2023; future deposits disclosed in financial statements.","Deposit earns variable interest; Enovix can withdraw interest if sufficient collateral remains.","Enovix cannot withdraw deposit without OCBC consent while loan outstanding; additional margin may be required.","Enovix indemnifies OCBC against losses from unenforceability, breach, or recovery failure of the loan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283700,"accession_number":"0001828318-23-000158","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-07-26T23:59:59+00:00","items":["1.01","2.02","9.01"],"status":"ready","headline":"Enovix signs YBS manufacturing deal for $70M funding; Q2 rev $42K, units beat plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["YBS agreement: $100M equipment investment, Enovix 30%/YBS 70% funded by OCBC; 10-year term.","Secured $70M non-dilutive funding for Fab2 in Malaysia; Gen2 Autoline samples targeted April 2024.","Q2 revenue $42K (10,000 cells); GAAP cost of revenue $14.2M, operating expenses $37.7M.","Fab1 produced 22,502 units (beat 18,000 plan); Q3 guidance ~36,000 units.","CapEx forecast lowered from $120M to $70M; cash $409.2M after $150M convertible debenture offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303241,"accession_number":"0001193125-23-178590","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-06-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix names Farhan Ahmad as CFO; outgoing CFO Steffen Pietzke to consult after July 9","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Steffen Pietzke resigns effective July 9, 2023; will provide consulting for up to 6 months in exchange for $400K RSU grant.","Farhan Ahmad appointed CFO effective July 10, 2023; previously VP Investor Relations & Finance Strategy at Micron Technology.","Ahmad receives $380K base salary, 60% target bonus, and $4M RSU vesting 1/5 after 12 months then monthly over 4 years.","Pietzke's severance includes 9 months' base salary, 18-month equity acceleration, and pro-rata bonus; no disagreement cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303240,"accession_number":"0001193125-23-174501","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-06-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Enovix appoints Joseph Malchow and Bernard Gutmann to board; expands to 8 directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Malchow (HNVR founding partner, ex-Enphase director) and Gutmann (former ON Semi CFO) join board effective June 22, 2023.","Board expands to eight members, six independent; Malchow on Compensation and Nominating committees; Gutmann on Audit.","Each new director receives annual cash retainers: $45k board service plus committee fees ($5k–$7.5k).","RSU grants: $275k vesting quarterly over 3 years plus $100k vesting over 1 year, per Non-Employee Director Compensation Policy.","Malchow served on Enovix's SPAC board (Dec 2020–Jul 2021); Gutmann brings 40 years semiconductor financial leadership."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303239,"accession_number":"0001828318-23-000115","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-06-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Enovix shareholders elect all six director nominees, approve say-on-pay and auditor at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected with majority support; broker non-votes ~40.3M shares.","Say-on-pay proposal approved with 58.0M for, 4.6M against, 286K abstain.","Advisory vote on frequency: 62.0M for one-year, 226K for two, 504K for three.","Ratification of Deloitte as FY2023 auditor approved with 102.7M for, 0.3M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303238,"accession_number":"0001628280-23-013227","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q1 production beats plan at 12,500 units; GAAP net loss $73.6M, non-GAAP loss $0.20/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Produced 12,500 full-qual units, beating plan of 9,000; 2.8x over Q4 2022's 4,442 units.","Revenue $21,000 from 3,000 qual samples; GAAP net loss $73.6M including $29.2M stock-based comp.","Non-GAAP net loss $31.6M ($0.20 diluted EPS); adjusted EBITDA loss $28.0M.","Closed $172.5M convertible debenture post-quarter; cash $293.8M plus ~$148.4M net proceeds.","Signed non-binding LOI with YBS for Fab 2 in Malaysia; seeking at least $70M non-dilutive financing."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":21000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303237,"accession_number":"0001628280-23-012433","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-04-21T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Enovix closes $172.5M convertible note offering at 3.00% due 2028; net proceeds ~$165.7M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $172.5M of 3.00% Convertible Senior Notes due 2028; includes $22.5M option exercise and $10M affiliate placement.","Conversion price ~$15.61/share, 15% premium over $13.57 close; capped calls entered to reduce dilution.","Net proceeds ~$165.7M after discounts & expenses; to fund second battery plant and Gen2 equipment.","Capped call transactions cap price initially $21.1692/share, 56% premium."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303236,"accession_number":"0001628280-23-011796","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-04-17T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Enovix Q1 Fab-1 output of 12,500 cells beats 9,000 forecast; seeks $70M non-dilutive financing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Produced 12,500 battery cells in Q1 ending Apr 2, 2023, exceeding forecast of 9,000 cells.","Full-year 2023 target of 180,000 wearable-size cells from Fab-1 remains unchanged.","Seeking at least $70 million in non-dilutive financing for next-gen manufacturing line in Penang, Malaysia.","Penang facility based on non-binding LOI with YBS International Berhad at Penang Science Park."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322871,"accession_number":"0001828318-23-000059","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-02-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Enovix Q4 2022 revenue $1.1M, net loss $11.2M; guides 180K cells in 2023","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2022 revenue $1.1M (service); GAAP net loss $11.2M ($0.07/share); Non-GAAP net loss $29.2M ($0.19/share).","Shipped 4,442 cells in Q4, exceeding internal goal; volume-weighted yield 42.9% (Q3: 16.4%).","Revenue funnel Active Design/Design Win grew 58% sequentially to $669M from $423M.","Guides Q1 2023 production of 9,000 cells (double Q4); full-year 2023 target 180,000 wearable-size cells.","2023 capex guidance $120M; net cash $322.9M; new COO Ajay Marathe appointed."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":6202000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322870,"accession_number":"0001828318-23-000026","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-01-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enovix appoints Gregory Reichow as Compensation Committee chair, adds Audit Committee role","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Gregory Reichow appointed chair of Compensation Committee effective Jan 24, 2023.","Appointed to Audit Committee effective Jan 25, 2023.","Will receive $10,000 annual retainer as Compensation Committee chair, paid quarterly.","Will receive $7,500 annual retainer as Audit Committee member, paid quarterly."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322869,"accession_number":"0001828318-23-000020","cik":1828318,"company_name":"Enovix Corp","ticker":"ENVX","form_type":"8-K","filed_at":"2023-01-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Enovix CTO to retire, CCO resigns; Ralph Schmitt appointed new CCO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CTO Ashok Lahiri retiring effective Feb 1, 2023; remains as advisory board lead.","GM & CCO Cameron Dales resigning effective same date; both departures amicable.","Ralph Schmitt, current SVP Sales, named Chief Commercial Officer effective Feb 1.","Lahiri receives 9-mo salary severance, 36-mo COBRA, full equity acceleration.","Dales receives 9-mo salary, 9-mo COBRA, 18-mo equity acceleration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1656875395.0279999,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2023-01-23T23:59:59+00:00|322869"}